ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Cancer

Non-Hodgkin Lymphoma trials near Valencia, VC, ESP:

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
Relapsed B-Cell Non-Hodgkin Lymphoma
Drug: Mosunetuzumab
Drug: Obinutuzumab

Phase 1

ADC Therapeutics

Valencia, Spain and 26 other locations

and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...

Enrolling
Hodgkin Disease
Lymphoma, Non-Hodgkin
Drug: Relatlimab
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Valencia, Spain and 73 other locations

is focused on patients with previously treated aggressive B-cell non-Hodgkin lymphoma whose cancer has stopped responding ...

Enrolling
B-Cell Non-Hodgkin Lymphoma (B-NHL)
Drug: Dexamethasone
Drug: Ifosfamide

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Valencia, Spain and 38 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...

Enrolling
Non-Hodgkin Lymphoma
Drug: Prednisone
Drug: Lenalidomide

Phase 2

Genmab
Genmab

L'Hospitalet de Llobregat, Barcelona, Spain and 74 other locations

additional open-label imaging feasibility sub-study using a tracer in adult participants with relpased/refractory B-cell non-Hodgkin...

Active, not recruiting
Non-Hodgkins Lymphoma
Drug: Tocilizumab
Drug: Atezolizumab

Phase 1, Phase 2

Roche
Roche

Valencia, Spain and 19 other locations

This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 or CC-99282) i...

Enrolling
Non-Hodgkin Lymphoma
Drug: IV Glofitamab
Drug: CC-99282

Phase 1

Roche
Roche

València, Valencia, Spain and 26 other locations

The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...

Active, not recruiting
Non Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Drug: tafasitamab
Drug: parsaclisib

Phase 1, Phase 2

Incyte
Incyte

Valencia, Spain and 49 other locations

according to the Lugano Classification of response in malignant lymphoma (Cheson, 2014) and as assessed by independent central review in eac-...

Enrolling
B-cell Non-Hodgkin Lymphoma (NHL)
Drug: Odronextamab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Valencia, Spain and 137 other locations

Phase 1 dose escalation study of ZN-d5 in subjects with relapsed or refractory non-Hodgkin lymphoma (NHL) or acute myeloid...

Enrolling
Non Hodgkin Lymphoma
Acute Myeloid Leukemia
Drug: ZN-d5

Phase 1

K-Group Alpha

Valencia, Spain and 13 other locations

and refractory multiple myeloma (RRMM) and relapsed and refractory non-Hodgkin lymphoma (RR-NHL), and determine the recomm...

Active, not recruiting
Neoplasm Malignant
Drug: SAR442257

Phase 1

Sanofi
Sanofi

Valencia, Spain and 15 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems